Mary Hu

Company: Shanghai Miracogen
Job title: Chief Executive Officer
Seminars:
Providing a Clinical Update of an EGFR Targeted ADC MRG003 11:45 am
Review the ADC landscape in China Investigate potent anti-tumour activity in preclinical studies Demonstrate manageable safety and promising efficacy in early phase clinical studiesRead more
day: Track C - Day 1 - AM